"Jesteśmy przychodnią medyczną zlokalizowaną na Targówku kilka kroków od stacji Metra - Trocka. Otaczamy profesjonalną opieką medyczną Pacjentów chorych na wrzodziejące zapalenie jelita grubego oraz chorobę Leśniewskiego - Crohna. Lekarze specjaliści, badania diagnostyczne i laboratoryjne, szereg badań USG, badania endoskopowe (kolonoskopia, gastroskopia czy rektoskopia) – jesteśmy dumni, że możemy zaproponować Państwu tak bogatą ofertę. Vivamed to również lekarze takich specjalności jak: kardiolog, ginekolog, diabetolog, endokrynolog, lekarz medycyny pracy, lekarz medycyny sportowej, pediatra i wiele innych. Zapraszamy Państwa do skorzystania z naszych usług."

During the past decade, NZOZ Vivamed conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 24 clinical trials were completed, i.e. on average, 64.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 17 clinical trials were completed. i.e. 340% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NZOZ Vivamed" #1 sponsor was "Shire" with 10 trials, followed by "Celgene" with 8 trials sponsored, "Galapagos NV" with 5 trials sponsored, "Takeda" with 5 trials sponsored and "Eli Lilly and Company" with 5 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NZOZ Vivamed" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Cosmo Technologies Ltd" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Nektar Therapeutics" with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "NZOZ Vivamed" are "Ulcerative Colitis" (26 trials), "Crohn's Disease" (12 trials), "Crohn Disease" (7 trials), "Colitis, Ulcerative" (6 trials) and "Crohn's Enteritis" (1 trials). Many other conditions were trialed in "NZOZ Vivamed" in a lesser frequency.

Most popular intervention types in "NZOZ Vivamed" are "Drug" (51 trials), "Other" (9 trials), "Biological" (3 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Filgotinib" (4 trials), "Ontamalimab" (4 trials), "Ozanimod" (4 trials) and "BMS-986165" (2 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Vivamed" are 53 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "NZOZ Vivamed". undefined are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in NZOZ Vivamed, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Vivamed, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".